CDXC Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced +301.54% ChromaDex Corporation price and volume Combination chart with 2 data series. Chart represents ChromaDex Corporation price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart has 2 ...
美股股票市场上受到广泛关注、具有显著行业影响力、市场表现活跃且市值规模较大的科技公司股票。显示的所有第三方徽标、品牌或商标仅用于识别目的,仍然是其各自所有者的财产。資訊由富途提供, 并非详尽无遗的有关主题概念股, 仅供参考。 展示条件: 美股科技股概念板块中涨跌幅首5位, 由高至低排列,实时市场数据。美股...
UnitedHealth stock plunges on report of DoJ Medicare Advantage probe UnitedHealth, still reeling from the murder of one of its top executives, is reportedly facing a Department of Justice investigation. UNH Jobs, Employment and Work News Feb 20, 2025 6:37 PM EST IRS makes a startling change...
$Chromadex Corporation(CDXC)$被忽视的潜力股,前途光明,用途广泛。 评论 0 狐狸长翅膀 东方财富 2024-11-05 2023年1季报开始每个季度不小于70%的增幅,知道最近一期开始盈利,顶,没办法顶到底 评论 0 狐狸长翅膀 东方财富 2024-11-04 两天干到目标价? 评论 0 股友qRabxd 东方财富 2024-...
We take the underlying stock price, the break even point (target price), the days to expiration, and the 52-week historical volatility, and then use those figures in this formula. Depending on the strategy, we use the above or below probability (i.e., the probability the price crosses th...
While ChromaDex has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not on...
Profit From Legal Insider Trading . Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. While he cannot provide investment advice or recommendations, Moreland appreciates your feedback;
对ChromaDex Corp(CDXC)给出Buy评级,目标价格由$8.00调整为$11.00。 0 0 转发(0) 评论(0) 分享 站内推送 收藏 投诉 Raghuram Selvaraju 03/10 ChromaDex Corp 估值:11.00 3月10日Raghuram Selvaraju - HC Wainwright & Co. 对ChromaDex Corp(CDXC)给出Buy评级,目标价格由$8.00调整为$11.00。 0 0...
《大行》大摩:本港公用股收益率吸引力较低 予长建(01038.HK)、电能(00006.HK)、中电(00002.HK)「与大市同步」评级 摩根士丹利发表研报指,由于香港公用股的收益率吸引力较低,因此将该板块股份评级定为「与大市同步」。该行解释,在美国十年期国债债券收益率高企的情况下,本港公用股收益率差距仍相对较低,预...
HC Wainwright & Co.:重申ChromaDex(CDXC.US)评级,由买入调整至买入评级, 目标价由11.00美元调整至11.00美元。 ChromaDex(CDXC.US)公司简介:ChromaDex Corp 是一家致力于健康老龄化的生物科技公司。该公司致力于研究随着年龄增长而下降的烟酰胺腺嘌呤二核苷酸(NAD+)。该公司是NAD+前体烟酰胺核糖苷(NR)的创新者,...